A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Trial details
- Registry ID
- NCT07023731
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationNCT07023731 | ARVN | Phase 1, Phase 2 | Completed | 2026-10-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |